Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • QuickFee bucks the trend for now amid BNPL industry decline
    • News

    QuickFee bucks the trend for now amid BNPL industry decline

    Buy Now Pay Later (BNPL) may not work well when it’s customer-oriented, as they might eventually see the dent in their wallet and walk away. However, if it is business-oriented, helping companies get paid on time, it might be a different story. Assisting businesses to keep track of their vendor or client payments, online payment

    Read More
    Public
  • Markets stalling out, will the bullishness continue?
    • Market Update

    Markets stalling out, will the bullishness continue?

    The XJO is expected to open flat this morning following both a similar move from the U.S last night and their flat futures this morning. As the U.S trades in the point of their ascending triangle, our market seems unwilling to break our own in any convincing manner. A couple of days ago we tried

    Read More
    Public
  • Freelancer reviews expenditure to seek return to profitability
    • News

    Freelancer reviews expenditure to seek return to profitability

    For Freelancer (ASX: FLN), a freelancing marketplace that only just reached cash flow breakeven, it sure knows how to push its luck. Despite recently getting back on track, the Company’s fortunes have taken a hit and it’s come as a bit of a surprise. Freelancer’s cash receipts for the first quarter of 2023, ending in

    Read More
    Public
  • Damaged nerves? Soft tissue regeneration can do a better job than sutures, says Orthocell
    • News

    Damaged nerves? Soft tissue regeneration can do a better job than sutures, says Orthocell

    Imagine being in a paralysing accident and then being able to use your limbs like before in little time. Not even movies often consider that possibility. That’s exactly what Western Australia-based regenerative medicine company Orthocell (ASX: OCC) aims to achieve with its product, Remplir, which replaces painful sutures with its soft tissue regeneration medical device.

    Read More
    Public
  • US markets continue higher on earnings, rising bond yields dampen XJO
    • Market Update

    US markets continue higher on earnings, rising bond yields dampen XJO

    The XJO is expected to edge lower on open this morning despite a small rally in the U.S overnight. Our meek opening may be chalked up to our rally yesterday predicting last night’s gains (and thus preemptively pricing it in) and flat to negative U.S futures this morning. Furthermore, we are consolidating near the top

    Read More
    Public
  • UNITH sets plan to offer digital humans that work for free under 2023 roadmap
    • News

    UNITH sets plan to offer digital humans that work for free under 2023 roadmap

    Known for facilitating corporations, including a Big 5 Tech company, in implementing real-time interactive digital avatars with humanised responses, artificial intelligence company UNITH (ASX: UNT) has big plans to introduce its Digital Human platform to a wider market under a freemium model. It follows the footsteps of companies like Grammarly, Spotify, Canva, and many more

    Read More
    Public
  • «
  • ‹
  • 256
  • 257
  • 258
  • 259
  • 260
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.